|
KMID : 0811720180220010063
|
|
Korean Journal of Physiology & Pharmacology
2018 Volume.22 No. 1 p.63 ~ p.70
|
|
|
Cilostazol attenuates kainic acid-induced hippocampal cell death
|
|
Park Young-Seop
Jin Zhen
Jeong Eun-Ae
Yi Chin-Ok
Lee Jong-Youl
Park In-Sung
Roh Gu-Seob
|
|
|
Abstract
|
|
|
|
Cilostazol is a selective inhibitor of type 3 phosphodiesterase (PDE3) and has been widely used as an antiplatelet agent. Cilostazol mediates this activity through effects on the cyclic adenosine monophosphate (cAMP) signaling cascade. Recently, it has attracted attention as a neuroprotective agent. However, little is known about cilostazol’s effect on excitotoxicity induced neuronal cell death. Therefore, this study evaluated the neuroprotective effect of cilostazol treatment against hippocampal neuronal damage in a mouse model of kainic acid (KA)-induced neuronal loss. Cilostazol pretreatment reduced KA-induced seizure scores and hippocampal neuron death. In addition, cilostazol pretreatment increased cAMP response element-binding protein (CREB) phosphorylation and decreased neuroinflammation. These observations suggest that cilostazol may have beneficial therapeutic effects on seizure activity and other neurological diseases associated with excitotoxicity.
|
|
|
KEYWORD
|
|
|
Cilostazol, Hippocampus, Kainic acid, Neuroinflammation, Neuronal death
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
  
|